Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis
Frédéric Preitner(Beth Israel Deaconess Medical Center), Barbara B. Kahn(Beth Israel Deaconess Medical Center), Nimesh Mody(University of Aberdeen), Odile D. Peroni(Beth Israel Deaconess Medical Center), Timothy E. Graham(Diabetes & Endocrinology Specialists)
American Journal of Physiology-Endocrinology and Metabolism
October 14, 2009
Cited by 106
Related Papers
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
|Nature Medicine|2002|4.2k
Obesity and insulin resistance
|Journal of Clinical Investigation|2000|3.2k
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
|Cell Metabolism|2005|2.8k